APA

Pettipher R., Vinall S. L., Xue L., Speight G., Townsend E. R., Gazi L., Whelan C. J., Armer R. E., Payton M. A. & Hunter M. G. (20120406). Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. : The Journal of pharmacology and experimental therapeutics.

Chicago

Pettipher Roy, Vinall Shân L, Xue Luzheng, Speight Graham, Townsend Elizabeth R, Gazi Lucien, Whelan Cliff J, Armer Richard E, Payton Mark A and Hunter Michael G. 20120406. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. : The Journal of pharmacology and experimental therapeutics.

Harvard

Pettipher R., Vinall S. L., Xue L., Speight G., Townsend E. R., Gazi L., Whelan C. J., Armer R. E., Payton M. A. and Hunter M. G. (20120406). Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. : The Journal of pharmacology and experimental therapeutics.

MLA

Pettipher Roy, Vinall Shân L, Xue Luzheng, Speight Graham, Townsend Elizabeth R, Gazi Lucien, Whelan Cliff J, Armer Richard E, Payton Mark A and Hunter Michael G. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. : The Journal of pharmacology and experimental therapeutics. 20120406.